COMPLETED

Improve Medication Adherence Among Stroke Survivors in Rural Kentucky

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To test the feasibility and promise of a combined intervention provided by community health worker (CHW) in collaboration with pharmacy technician and pharmacist to improve hypertension and long-term stroke outcomes by identifying and reducing barriers to medication adherence among ischemic stroke survivors. This collaborative intervention involves a self-management program including an educational session on practical strategies to improve hypertension control (i.e., appropriately taking medications, necessity of treatment, and consequences of not taking medicine, etc.), complemented by individually-tailored sessions to identify and address barriers to medication adherence.

Official Title

Intervention to Improve Medication Adherence Among Stroke Survivors in Rural Kentucky

Quick Facts

Study Start:2025-07-24
Study Completion:2025-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT07084051

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:30 Years to 90 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adult patients with history of ischemic stroke or transient ischemic attack (TIA) in the past 2 years
  2. * residing in a rural county in Kentucky
  1. * significant aphasia
  2. * cognitive impairment
  3. * a terminal illness
  4. * other neurologic deficits that would impede from providing informed consent or meaningfully participate in the one-to-one sessions.
  5. * a prior aneurysmal subarachnoid hemorrhage and or aneurysm, cerebral venous sinus thrombosis, vasculitis, blood clotting disorder due to genetic causes
  6. * if the patient does not take any secondary preventative medications

Contacts and Locations

Principal Investigator

Hend Mansoor, PharmD, PhD
PRINCIPAL_INVESTIGATOR
University of Kentucky

Study Locations (Sites)

University of Kentucky
Lexington, Kentucky, 40356
United States

Collaborators and Investigators

Sponsor: Hend Mansoor

  • Hend Mansoor, PharmD, PhD, PRINCIPAL_INVESTIGATOR, University of Kentucky

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-07-24
Study Completion Date2025-12-31

Study Record Updates

Study Start Date2025-07-24
Study Completion Date2025-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Stroke (CVA) or Transient Ischemic Attack